| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Robert Brenner is Chief Medical Officer at VERA. Robert Brenner's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.6M at current prices.
The VERA filings lean toward selling, a net 2,151 shares.
Robert Brenner has 4 Form 4 filings on record from January 2024 to February 2026, all as Chief Medical Officer at Vera Therapeutics (VERA), 2024–2026.
The 6 reported transactions were 3 option or other derivative awards, 2 stock awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $90K.
The only open-market sale was 2,151 shares of VERA at an average $41.98 on February 23, 2026, about $90K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | Chief Medical Officer | Sell | 2,151 | $41.98 | $90,307.37 | -4.1% | -18.4% | - |